# A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

> **NCT00203008** · — · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 2106 (actual)

## Conditions studied

- Parkinson's Disease
- Malignant Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00203008
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 2106 (ACTUAL)
- **Last updated:** 2010-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203008, "A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00203008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*